Jia-Sheng Wang

Jia-Sheng Wang

Auto-generated profile, based on publicly available information

Jia-Sheng Wang

Department of Environmental Health Science, University of Georgia, Athens, Georgia, USA

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2011 in Food Additives & Contaminants: Part A
Verified
Journal Article
Closed access
GSG. Sun
G. Sun
SWS. Wang
S. Wang
XHX. Hu
X. Hu
JSJ. Su
J. Su
YZY. Zhang
Y. Zhang
JWJ.-S. Wang
J.-S. Wang
Aflatoxins and fumonisins are ubiquitous foodborne toxicants and the co-occurrence of these mycotoxins in human foods represents a significant public health concern, which has been strongly associated with human aflatoxicosis, neural tube defects, as well as many types of primary cancers. In this study the co-contamination of aflatoxin B1 (AFB1) and fumonisin B1 (FB1) in food and human dietary exposure was investigated in residents of three different areas of China. A total of 209 food samples were measured for AFB1 and FB1. The median AFB1 levels were 13.5, 2.3 and 1.3 µg kg−1 and the median FB1 levels were 2.6, 0.4 and 0.3 mg kg−1 in corn samples collected from Huaian (a high-risk area for oesophageal cancer), Fusui (a high-risk area for liver cancer) and Huantai (a low-risk area for both oesophageal and liver cancers), respectively. The median level of AFB1 in plant oil of Fusui was the highest (52.3 µg kg−1) among all food samples analysed. Co-contamination of these two mycotoxins was found in corn, rice and wheat flour. Based on measured food consumption data, the averaged daily dietary intake of AFB1 was 0.397 µg (range = 0.269–1.218 µg) in residents of Huantai, 1.723 µg (0.224–49.772 µg) in Huaian, and 2.685 µg (1.006–14.534 µg) in Fusui. The averaged FB1 daily dietary intake was 92.4 µg (range = 55.0–362.1 µg) for residents of Huantai, 460.0 µg (83.2–2894.5 µg) in Huaian, and 138.6 µg (30.0–10,541.6 µg) in Fusui. These data suggest that the co-exposure to AFB1 and FB1 in residents of rural China may contribute to the aetiology of human chronic diseases in high-risk areas.

19 March 2013 in Journal of Applied Toxicology
Verified
Journal Article
Closed access
PDF file
GQGuoqing Qian
Guoqing Qian
LTLili Tang
Lili Tang
XGXia Guo
Xia Guo
FWFranklin Wang
Franklin Wang
MMMichael E. Massey
Michael E. Massey
JWJia‐Sheng Wang
Jia‐Sheng Wang

25 November 2015 in Toxicological Sciences
Verified
Journal Article
Open access
PDF file
JWJincheng Wang
Jincheng Wang
LTLili Tang
Lili Tang
TGTravis C. Glenn
Travis C. Glenn
JWJia-Sheng Wang
Jia-Sheng Wang
Aflatoxins are a group of potent foodborne toxicants naturally occurring in maize and groundnuts. Differential species-specific sensitivity to aflatoxins has been documented but cannot be fully explained by the differences in metabolism of these toxicants among animal species. Commensal microbial communities (microbiota) are critical to human and animal health, but few studies have assessed interactions between xenobiotic toxins and those microbiota, and its potential effects to humans and animals. Here, an exploratory dosing experiment was conducted to explore effects of Aflatoxin B1 (AFB1) on the gut microbiota in a commonly used rat model. Male F344 rats were randomly divided into groups and treated with different concentrations of AFB1. Microbial communities in fecal samples were assessed using 16S rRNA sequence analysis. We found that samples from the control group had a phylogenetically diverse community, and that increasing AFB1 doses decreased this diversity but increased evenness of community composition. In addition, the gut microbiota from different samples was clustered according to their dosing regimens. There is no community shift at the phylum level but some lactic acid bacteria were significantly depleted by AFB1. These findings suggested that AFB1 could modify the gut microbiota in a dose-dependent manner.

1 June 2018 in The Journal of Nutritional Biochemistry
Verified
Journal Article
Closed access
JWJincheng Wang
Jincheng Wang
LTLili Tang
Lili Tang
HZHongyuan Zhou
Hongyuan Zhou
JZJun Zhou
Jun Zhou
TGTravis C Glenn
Travis C Glenn
JWJia-Sheng Wang
Jia-Sheng Wang

20 April 2018 in Toxicological Sciences
Verified
Journal Article
Closed access
PDF file
JZJun Zhou
Jun Zhou
LTLili Tang
Lili Tang
JWJincheng Wang
Jincheng Wang
JWJia-Sheng Wang
Jia-Sheng Wang
In this study, male F344 rats were orally exposed to aflatoxin B1 (AFB1) at 0, 5, 25, and 75 μg/kg for four weeks. Rat feces were collected from 2–4 weeks following exposure and were assessed for gut-microbiota dependent metabolites. Gut-microbiota related organic acids were quantitated in the feces using 2-nitrophenylhydrazine derivatization coupled HPLC-profiling method which was validated and showed good reliability, accuracy and sensitivity. After 2-week exposure, AFB1 significantly reduced the levels of fecal short chain fatty acids (SCFAs) with an over 70% reduction in the high-dose group (75 μg/kg). Mixed-effects model revealed an inverse correlation between AFB1 dose and fecal levels of SCFAs, but no significant time effect was found. Compared with the control, oral exposure to middle-dose AFB1 (25 μg/kg) resulted in remarkable elevations of fecal cholic acid (2.18-fold), linoleic acid (cis-9,cis-12-18:2) (11.3-fold), pentadecanoic acid (15:0) (3.68-fold), pyruvic acid (4.56-fold) and 3-phenyllactic acid (3.74-fold), but deoxycholic acid level was reduced by 41% in the low-dose group (5 μg/kg). These results demonstrated the disruptions of several important gut-microbiota metabolic pathways, including the synthesis of SCFAs, pyruvic acid related pathways, metabolisms of amino acids, bile acids and long chain fatty acids, which may further affect host digestive efficiency, energy supply, intestinal immunity, production of neurotransmitters, and enterohepatic cross-talk. Our study suggests that the impairment of gut-microbiota dependent metabolism may contribute to pathological mechanisms of AFB1-induced adverse health effects.